About Birocell
Birocell is a company based in Anyang (South Korea) founded in 2019. It operates as a B2B. Birocell offers products and services including PBS, DPBS, MCDB131, IMDM, and Ham's F10. Birocell operates in a competitive market with competitors including Multus, Metatissue, Nu-Tek Biosciences, Kohjin Bio and Sarvoshadhi Bio, among others.
- Headquarter Anyang, South Korea
- SectorsHealthcareIndustrial Goods & Manufacturing
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website birocell.com
- Legal Name 주식회사 더바이로셀
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of Birocell
Birocell operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Birocell
Birocell offers a comprehensive portfolio of products and services, including PBS, DPBS, MCDB131, IMDM, and Ham's F10.
Buffer solution used for washing and transporting cells.
Phosphate-buffered saline for cell maintenance and processing.
Specialized medium for supporting cell growth in research.
Medium designed for immune cell cultivation and experiments.
Nutrient medium for animal cell lines and tissue culture.
Competitors of Birocell
Birocell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multus, Metatissue, Nu-Tek Biosciences, Kohjin Bio and Sarvoshadhi Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| multus.bio | 2019 | London, United Kingdom | $9.3M | 8 | Provider of lab-grown meat alternatives | |
| metatissue.com | 2018 | Ilhavo, Portugal | – | – | Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications | |
| nu-tekbiosciences.com | 2008 | Minnetonka, United States | – | – | Develops innovative animal-free peptones and cell culture media for pharmaceutical use. | |
| kohjin-bio.jp | 1981 | Sakado, Japan | – | – | Tissue culture media provided for regenerative medicine and immunotherapy research. | |
| sarvoshadhi.com | 2017 | Kolhapur, India | – | – | Customized cell culture media for biotechnology are developed. | |
| metaboliq.ca | 2022 | Canada | – | – | Developer of cell culture medium for pharmaceutical screening and personalized medicine | |
| onkologic.com | 2021 | Farmington, United States | $305,000 | – | NK cell culture media is developed for cancer cell therapies. | |
| alt-biotech.com | 2023 | Evry Courcouronnes, France | – | – | Delivers comprehensive cell-culture solutions for producing non-therapeutic recombinant proteins. | |
| cet.bio | 2000 | Coralville, United States | $45,000 | – | Cell lines and stem cell products are supplied to researchers. |
Detailed competitors of Birocell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Birocell
The website of Birocell (birocell.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Birocell. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Birocell
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Birocell
10 companies that operate in the same segment as Birocell (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 300 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Birocell
Birocell was founded in 2019.
Birocell is headquartered in Anyang, South Korea. It is registered at Anyang, Gyeonggi-do, South Korea.
The Birocell is a biotechnology company specializing in researching and developing serum-free media for immune and animal cell culture. It provides customized manufacturing services and products like buffers and media solutions. Based in Anyang-si, South Korea, the company focuses on advancing cell culture technologies through RD and partnerships. Their activities include producing items such as PBS and IMDM, serving sectors like life sciences without specific client details.
Birocell's top competitors include Multus, Onkologic and Cellular Engineering Technologies.
Birocell offers PBS, DPBS, MCDB131, IMDM, and Ham's F10.
Birocell operates through ,.
The website of Birocell receives about 681 thousand visits a month.